News

CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
Society / Forget Kennedy’s faux-populist, anti-science approach. The former FTC chair provides the real model of an ideal HHS ...